위내 풍선 시장 : 유형별, 충전 재료별, 최종사용자별 - 세계 기회 분석 및 산업 예측(2024-2033년)

Intragastric Balloons Market By Type (Single, Dual, Triple), By Filling Material (Gas Filled, Saline Filled) By End User (Hospitals, Ambulatory Surgical Centers, Others) : Global Opportunity Analysis and Industry Forecast, 2024-2033

US $ 4,425 ￦ 6,094,000

PDF (Business License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄는 5회 가능하며, 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다. 2명 이상이 이용할 경우, 추가 요금을 지불하여 라이선스 업그레이드로 최대 5명까지 이용 가능합니다.

US $ 7,412 ￦ 10,207,000

PDF (Enterprise User License) & Excel (Data Pack) & Free Update

PDF 보고서 및 Excel 데이터를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다. 보고서 업데이트 서비스가 무료로 제공됩니다.

한글목차

세계 위내 풍선 시장은 2023년 3,220만 달러로 평가되며 2024-2033년 연평균 13.6% 성장하여 2033년에는 1억 1,530만 달러에 달할 것으로 예상됩니다.

위내 풍선은 수술이 필요 없는 의료기기로, 위 내 공간을 확보하여 포만감을 주고 식사량을 줄여 체중 감량을 돕기 위해 개발되었습니다. 이 풍선은 내시경 수술을 통해 위장에 넣어 식염수 또는 가스로 채워져 위장의 일부를 차지하여 식사 섭취 능력을 감소시킵니다. 이 방법은 저칼로리 식단을 지키고, 더 건강한 식습관을 개발하고 체중 감량을 지원합니다. 이 풍선은 위 우회술이나 슬리브 위 절제술과 같은 수술을 받을 자격이 없거나 피하고 싶은 비만 환자에게 특히 유리합니다.

위내 풍선 시장의 성장을 주도하는 것은 좌식 생활습관, 건강에 해로운 식습관, 유전적 소인 등 다양한 요인과 관련된 비만율의 증가입니다. 이러한 요인들이 전 세계적으로 확산됨에 따라 비만 발생률은 지속적으로 증가하고 있습니다. 그 결과, 이러한 건강 위험을 줄이고 전반적인 건강을 개선하기 위해 효과적인 체중 감량 솔루션을 찾는 사람들이 증가하고 있습니다. 이러한 비만 관리 솔루션에 대한 수요 증가는 체중 감량에 대한 최소침습적 접근 방식을 제공하는 위내 풍선과 같은 중재 시장을 주도하고 있습니다. 예를 들어, 최소침습적 치료를 원하는 환자의 57.0%는 최소침습적 치료를 권유받고 치료 후의 단점을 잘 인지하지 못하는 것으로 보고되어 의료 전문가의 영향을 받아 결정을 내린 것으로 나타났습니다.

그러나, 보험 적용의 부족은 위내 풍선 도입의 걸림돌로 작용하고 있습니다. 많은 의료 시스템에서 위내 풍선 치료에 대한 보험 적용이 미흡하거나 아예 없는 경우가 많으며, 이로 인해 환자가 부담해야 하는 본인부담금이 매우 높습니다. 이러한 경제적 장벽은 특히 경제적으로 여유가 없거나 보험 적용이 불충분한 환자들이 치료를 받는 것을 주저하게 만듭니다. 한편, 신제품의 채택은 시장 성장에 유리한 기회를 설명합니다. 예를 들어, 2022년 9월 미국 의료기기 제조업체인 Allurion Technologies는 인도에서 체중 감량 솔루션인 삼킬 수 있는 위 풍선을 출시했습니다. 이 제품은 16주 이내에 평균 10-15%의 체중을 감량할 수 있다고 합니다.

부문 개요

위내 풍선 산업은 유형, 충전 재료, 최종사용자 및 지역으로 분류됩니다. 유형에 따라 단일, 이중, 삼중으로 분류됩니다. 충전재에 따라 가스 충전형과 식염수 충전형으로 나뉩니다. 최종사용자에 따라 병원, 외래 수술 센터(ASC), 기타로 분류됩니다. 지역별로는 북미, 유럽, 아시아태평양, 라틴아메리카, 중동 및 아프리카로 분석됩니다.

주요 조사 결과

유형별로는 2023년 위내 풍선 시장에서 가장 큰 수익을 창출한 것은 단일 부문이었습니다.

충진재별로는 식염수 충진 부문이 2023년 시장에서 가장 높은 점유율을 차지했습니다.

최종사용자별로는 병원 부문이 2023년 가장 큰 시장 점유율을 차지했습니다.

지역별로는 북미가 2023년 위내 풍선 시장을 장악했습니다.

경쟁 시나리오

이 보고서는 사용자 정의가 가능합니다.

• 규제 가이드라인
• 고객의 관심사에 따른 추가 기업 개요
• 국가별 또는 지역별 추가 분석 - 시장 규모 및 전망
• 기업 개요 확대 목록
• 과거 시장 데이터

목차

제1장 소개

제2장 주요 요약

제3장 시장 상황

• 시장 정의와 범위
• 주요 조사 결과
  • 주요 투자 기회
  • 주요 성공 전략
• Porter's Five Forces 분석
• 시장 역학
  • 성장 촉진요인
  • 성장 억제요인
  • 기회

제4장 위내 풍선 시장 : 유형별

• 시장 개요
• 싱글
• 듀얼
• 트리플

제5장 위내 풍선 시장 : 충전 재료별

• 시장 개요
• 가스 충전
• 생리식염수 충전

제6장 위내 풍선 시장 : 최종사용자별

• 시장 개요
• 병원
• 외래 수술 센터
• 기타

제7장 위내 풍선 시장 : 지역별

• 시장 개요
• 북미
  • 주요 시장 동향과 기회
  • 미국의 위내 풍선 시장
  • 캐나다의 위내 풍선 시장
  • 멕시코의 위내 풍선 시장
• 유럽
  • 주요 시장 동향과 기회
  • 프랑스의 위내 풍선 시장
  • 독일의 위내 풍선 시장
  • 이탈리아의 위내 풍선 시장
  • 스페인의 위내 풍선 시장
  • 영국의 위내 풍선 시장
  • 기타 유럽 위내 풍선 시장
• 아시아태평양
  • 주요 시장 동향과 기회
  • 중국의 위내 풍선 시장
  • 일본의 위내 풍선 시장
  • 인도의 위내 풍선 시장
  • 한국의 위내 풍선 시장
  • 호주의 위내 풍선 시장
  • 기타 아시아태평양의 위내 풍선 시장
• 라틴아메리카, 중동 및 아프리카
  • 주요 시장 동향과 기회
  • 브라질의 위내 풍선 시장
  • 남아프리카공화국 위내 풍선 시장
  • 사우디아라비아의 위내 풍선 시장
  • 기타 라틴아메리카, 중동 및 아프리카의 위내 풍선 시장

제8장 경쟁 상황

• 소개
• 주요 성공 전략
• 주요 10개 기업 제품 매핑
• 경쟁 대시보드
• 경쟁 히트맵
• 주요 기업의 포지셔닝(2023년)

제9장 기업 개요

• Obalon Therapeutics
• Apollo Endosurgery Inc.
• Allurion Technologies Inc.
• Spatz Medical
• ReShape Lifesciences
• Lexel Medical
• Endalis
• MEDSIL
• Silimed Industria De Implantes Ltda.

ksm

영문 목차

영문목차

The global intragastric balloons market was valued at $32.2 million in 2023, and is projected to reach $115.3 million by 2033, growing at a CAGR of 13.6% from 2024 to 2033.

Intragastric balloons are medical devices that do not require surgery and are created to aid in weight loss by taking up space in the stomach, leading to a sensation of fullness and decreased food consumption. These balloons are placed in the stomach through an endoscopic procedure and are filled with saline or gas to occupy a part of the stomach, reducing its capacity for food intake. This method helps people stick to low-calorie diets and develop healthier eating habits, which in turn supports weight loss. These balloons are especially advantageous for individuals dealing with obesity who may not be eligible for or prefer to avoid surgical procedures such as gastric bypass or sleeve gastrectomy.

The growth of the intragastric balloons market is driven by rise in the obesity rates related to various factors such as sedentary lifestyles, unhealthy dietary habits, and genetic predispositions. As these factors become more prevalent globally, the incidence of obesity continues to rise. Consequently, individuals are increasingly seeking effective weight loss solutions to mitigate these health risks and improve their overall well-being. This growing demand for obesity management solutions drives the market for interventions such as intragastric balloons, which offer a minimally invasive approach to weight loss. For instance, 57.0% of the patients who preferred minimally invasive treatment made their decision under the influence of the healthcare professionals as they recommended minimally invasive treatment and reported less perceived disadvantages following their treatment.

However, lack of reimbursement policies hinders the adoption of intragastric balloons. In many healthcare systems, the coverage for intragastric balloon procedures is expected to be insufficient or non-existent, resulting in high out-of-pocket costs for patients. This financial barrier deters individuals from seeking treatment, particularly those with limited financial resources or inadequate insurance coverage. On the other hand, introduction of new products offers lucrative opportunities for the growth of the market. For instance, in September 2022, Allurion Technologies, the U.S.-based medical device manufacturer, launched its weight loss solution, a swallowable gastric balloon, in India. The product claims to reduce weight by 10-15% on average within 16 weeks.

Segmentation Overview

The intragastric balloons industry is segmented into type, filling material, end user, and region. By type, the market is classified into single, dual, and triple. Depending on the filling material, it is bifurcated into gas filled and saline filled. According to end user, the market is categorized into hospitals, ambulatory surgical centers (ASC), and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

By type, the single segment generated the largest revenue in the intragastric balloons market in 2023.

Depending on the filling material, the saline filled segment held the highest share in the market in 2023.

According to end users, the hospitals segment accounted for the largest market share in 2023.

Region wise, North America dominated the intragastric balloons market in 2023.

Competitive Scenario

The major players operating in the intragastric balloons market include Obalon Therapeutics, Apollo Endosurgery Inc., Allurion Technologies Inc., Spatz Medical, ReShape Lifesciences, Lexel Medical, Endalis, MEDSIL, and Silimed. Other players in the intragastric balloons market include Districlass Medical, and Helioscopie. These players have adopted several strategies, including mergers & acquisitions, partnerships, collaborations, and product innovation & diversification to maintain their foothold in the market.

Additional benefits you will get with this purchase are:

• Quarterly Update and* (only available with a corporate license, on listed price)
• 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
• Free Upcoming Version on the Purchase of Five and Enterprise User License.
• 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
• 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
• Free data Pack on the Five and Enterprise User License. (Excel version of the report)
• Free Updated report if the report is 6-12 months old or older.
• 24-hour priority response*
• Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

• Regulatory Guidelines
• Additional company profiles with specific to client's interest
• Additional country or region analysis- market size and forecast
• Expanded list for Company Profiles
• Historic market data

Key Market Segments

By Type

• Single
• Dual
• Triple

By Filling Material

• Gas Filled
• Saline Filled

By End User

• Hospitals
• Ambulatory Surgical Centers
• Others

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • France
  • Germany
  • Italy
  • Spain
  • UK
  • Rest of Europe
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia-Pacific
• LAMEA
  • Brazil
  • South Africa
  • Saudi Arabia
  • Rest of LAMEA

Key Market Players:

• Obalon Therapeutics
• Apollo Endosurgery Inc.
• Allurion Technologies Inc.
• Spatz Medical
• ReShape Lifesciences
• Lexel Medical
• Endalis
• MEDSIL
• Silimed Industria de Implantes Ltda.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

• 1.1. Report Description
• 1.2. Key Market Segments
• 1.3. Key Benefits
• 1.4. Research Methodology
  • 1.4.1. Primary Research
  • 1.4.2. Secondary Research
  • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

• 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

• 3.1. Market Definition and Scope
• 3.2. Key Findings
  • 3.2.1. Top Investment Pockets
  • 3.2.2. Top Winning Strategies
• 3.3. Porter's Five Forces Analysis
  • 3.3.1. Bargaining Power of Suppliers
  • 3.3.2. Threat of New Entrants
  • 3.3.3. Threat of Substitutes
  • 3.3.4. Competitive Rivalry
  • 3.3.5. Bargaining Power among Buyers
• 3.5. Market Dynamics
  • 3.5.1. Drivers
  • 3.5.2. Restraints
  • 3.5.3. Opportunities

CHAPTER 4: INTRAGASTRIC BALLOONS MARKET, BY TYPE

• 4.1. Market Overview
  • 4.1.1 Market Size and Forecast, By Type
• 4.2. Single
  • 4.2.1. Key Market Trends, Growth Factors and Opportunities
  • 4.2.2. Market Size and Forecast, By Region
  • 4.2.3. Market Share Analysis, By Country
• 4.3. Dual
  • 4.3.1. Key Market Trends, Growth Factors and Opportunities
  • 4.3.2. Market Size and Forecast, By Region
  • 4.3.3. Market Share Analysis, By Country
• 4.4. Triple
  • 4.4.1. Key Market Trends, Growth Factors and Opportunities
  • 4.4.2. Market Size and Forecast, By Region
  • 4.4.3. Market Share Analysis, By Country

CHAPTER 5: INTRAGASTRIC BALLOONS MARKET, BY FILLING MATERIAL

• 5.1. Market Overview
  • 5.1.1 Market Size and Forecast, By Filling Material
• 5.2. Gas Filled
  • 5.2.1. Key Market Trends, Growth Factors and Opportunities
  • 5.2.2. Market Size and Forecast, By Region
  • 5.2.3. Market Share Analysis, By Country
• 5.3. Saline Filled
  • 5.3.1. Key Market Trends, Growth Factors and Opportunities
  • 5.3.2. Market Size and Forecast, By Region
  • 5.3.3. Market Share Analysis, By Country

CHAPTER 6: INTRAGASTRIC BALLOONS MARKET, BY END USER

• 6.1. Market Overview
  • 6.1.1 Market Size and Forecast, By End User
• 6.2. Hospitals
  • 6.2.1. Key Market Trends, Growth Factors and Opportunities
  • 6.2.2. Market Size and Forecast, By Region
  • 6.2.3. Market Share Analysis, By Country
• 6.3. Ambulatory Surgical Centers
  • 6.3.1. Key Market Trends, Growth Factors and Opportunities
  • 6.3.2. Market Size and Forecast, By Region
  • 6.3.3. Market Share Analysis, By Country
• 6.4. Others
  • 6.4.1. Key Market Trends, Growth Factors and Opportunities
  • 6.4.2. Market Size and Forecast, By Region
  • 6.4.3. Market Share Analysis, By Country

CHAPTER 7: INTRAGASTRIC BALLOONS MARKET, BY REGION

• 7.1. Market Overview
  • 7.1.1 Market Size and Forecast, By Region
• 7.2. North America
  • 7.2.1. Key Market Trends and Opportunities
  • 7.2.2. Market Size and Forecast, By Type
  • 7.2.3. Market Size and Forecast, By Filling Material
  • 7.2.4. Market Size and Forecast, By End User
  • 7.2.5. Market Size and Forecast, By Country
  • 7.2.6. U.S. Intragastric Balloons Market
    • 7.2.6.1. Market Size and Forecast, By Type
    • 7.2.6.2. Market Size and Forecast, By Filling Material
    • 7.2.6.3. Market Size and Forecast, By End User
  • 7.2.7. Canada Intragastric Balloons Market
    • 7.2.7.1. Market Size and Forecast, By Type
    • 7.2.7.2. Market Size and Forecast, By Filling Material
    • 7.2.7.3. Market Size and Forecast, By End User
  • 7.2.8. Mexico Intragastric Balloons Market
    • 7.2.8.1. Market Size and Forecast, By Type
    • 7.2.8.2. Market Size and Forecast, By Filling Material
    • 7.2.8.3. Market Size and Forecast, By End User
• 7.3. Europe
  • 7.3.1. Key Market Trends and Opportunities
  • 7.3.2. Market Size and Forecast, By Type
  • 7.3.3. Market Size and Forecast, By Filling Material
  • 7.3.4. Market Size and Forecast, By End User
  • 7.3.5. Market Size and Forecast, By Country
  • 7.3.6. France Intragastric Balloons Market
    • 7.3.6.1. Market Size and Forecast, By Type
    • 7.3.6.2. Market Size and Forecast, By Filling Material
    • 7.3.6.3. Market Size and Forecast, By End User
  • 7.3.7. Germany Intragastric Balloons Market
    • 7.3.7.1. Market Size and Forecast, By Type
    • 7.3.7.2. Market Size and Forecast, By Filling Material
    • 7.3.7.3. Market Size and Forecast, By End User
  • 7.3.8. Italy Intragastric Balloons Market
    • 7.3.8.1. Market Size and Forecast, By Type
    • 7.3.8.2. Market Size and Forecast, By Filling Material
    • 7.3.8.3. Market Size and Forecast, By End User
  • 7.3.9. Spain Intragastric Balloons Market
    • 7.3.9.1. Market Size and Forecast, By Type
    • 7.3.9.2. Market Size and Forecast, By Filling Material
    • 7.3.9.3. Market Size and Forecast, By End User
  • 7.3.10. UK Intragastric Balloons Market
    • 7.3.10.1. Market Size and Forecast, By Type
    • 7.3.10.2. Market Size and Forecast, By Filling Material
    • 7.3.10.3. Market Size and Forecast, By End User
  • 7.3.11. Rest of Europe Intragastric Balloons Market
    • 7.3.11.1. Market Size and Forecast, By Type
    • 7.3.11.2. Market Size and Forecast, By Filling Material
    • 7.3.11.3. Market Size and Forecast, By End User
• 7.4. Asia-Pacific
  • 7.4.1. Key Market Trends and Opportunities
  • 7.4.2. Market Size and Forecast, By Type
  • 7.4.3. Market Size and Forecast, By Filling Material
  • 7.4.4. Market Size and Forecast, By End User
  • 7.4.5. Market Size and Forecast, By Country
  • 7.4.6. China Intragastric Balloons Market
    • 7.4.6.1. Market Size and Forecast, By Type
    • 7.4.6.2. Market Size and Forecast, By Filling Material
    • 7.4.6.3. Market Size and Forecast, By End User
  • 7.4.7. Japan Intragastric Balloons Market
    • 7.4.7.1. Market Size and Forecast, By Type
    • 7.4.7.2. Market Size and Forecast, By Filling Material
    • 7.4.7.3. Market Size and Forecast, By End User
  • 7.4.8. India Intragastric Balloons Market
    • 7.4.8.1. Market Size and Forecast, By Type
    • 7.4.8.2. Market Size and Forecast, By Filling Material
    • 7.4.8.3. Market Size and Forecast, By End User
  • 7.4.9. South Korea Intragastric Balloons Market
    • 7.4.9.1. Market Size and Forecast, By Type
    • 7.4.9.2. Market Size and Forecast, By Filling Material
    • 7.4.9.3. Market Size and Forecast, By End User
  • 7.4.10. Australia Intragastric Balloons Market
    • 7.4.10.1. Market Size and Forecast, By Type
    • 7.4.10.2. Market Size and Forecast, By Filling Material
    • 7.4.10.3. Market Size and Forecast, By End User
  • 7.4.11. Rest of Asia-Pacific Intragastric Balloons Market
    • 7.4.11.1. Market Size and Forecast, By Type
    • 7.4.11.2. Market Size and Forecast, By Filling Material
    • 7.4.11.3. Market Size and Forecast, By End User
• 7.5. LAMEA
  • 7.5.1. Key Market Trends and Opportunities
  • 7.5.2. Market Size and Forecast, By Type
  • 7.5.3. Market Size and Forecast, By Filling Material
  • 7.5.4. Market Size and Forecast, By End User
  • 7.5.5. Market Size and Forecast, By Country
  • 7.5.6. Brazil Intragastric Balloons Market
    • 7.5.6.1. Market Size and Forecast, By Type
    • 7.5.6.2. Market Size and Forecast, By Filling Material
    • 7.5.6.3. Market Size and Forecast, By End User
  • 7.5.7. South Africa Intragastric Balloons Market
    • 7.5.7.1. Market Size and Forecast, By Type
    • 7.5.7.2. Market Size and Forecast, By Filling Material
    • 7.5.7.3. Market Size and Forecast, By End User
  • 7.5.8. Saudi Arabia Intragastric Balloons Market
    • 7.5.8.1. Market Size and Forecast, By Type
    • 7.5.8.2. Market Size and Forecast, By Filling Material
    • 7.5.8.3. Market Size and Forecast, By End User
  • 7.5.9. Rest of LAMEA Intragastric Balloons Market
    • 7.5.9.1. Market Size and Forecast, By Type
    • 7.5.9.2. Market Size and Forecast, By Filling Material
    • 7.5.9.3. Market Size and Forecast, By End User

CHAPTER 8: COMPETITIVE LANDSCAPE

• 8.1. Introduction
• 8.2. Top Winning Strategies
• 8.3. Product Mapping of Top 10 Player
• 8.4. Competitive Dashboard
• 8.5. Competitive Heatmap
• 8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

• 9.1. Obalon Therapeutics
  • 9.1.1. Company Overview
  • 9.1.2. Key Executives
  • 9.1.3. Company Snapshot
  • 9.1.4. Operating Business Segments
  • 9.1.5. Product Portfolio
  • 9.1.6. Business Performance
  • 9.1.7. Key Strategic Moves and Developments
• 9.2. Apollo Endosurgery Inc.
  • 9.2.1. Company Overview
  • 9.2.2. Key Executives
  • 9.2.3. Company Snapshot
  • 9.2.4. Operating Business Segments
  • 9.2.5. Product Portfolio
  • 9.2.6. Business Performance
  • 9.2.7. Key Strategic Moves and Developments
• 9.3. Allurion Technologies Inc.
  • 9.3.1. Company Overview
  • 9.3.2. Key Executives
  • 9.3.3. Company Snapshot
  • 9.3.4. Operating Business Segments
  • 9.3.5. Product Portfolio
  • 9.3.6. Business Performance
  • 9.3.7. Key Strategic Moves and Developments
• 9.4. Spatz Medical
  • 9.4.1. Company Overview
  • 9.4.2. Key Executives
  • 9.4.3. Company Snapshot
  • 9.4.4. Operating Business Segments
  • 9.4.5. Product Portfolio
  • 9.4.6. Business Performance
  • 9.4.7. Key Strategic Moves and Developments
• 9.5. ReShape Lifesciences
  • 9.5.1. Company Overview
  • 9.5.2. Key Executives
  • 9.5.3. Company Snapshot
  • 9.5.4. Operating Business Segments
  • 9.5.5. Product Portfolio
  • 9.5.6. Business Performance
  • 9.5.7. Key Strategic Moves and Developments
• 9.6. Lexel Medical
  • 9.6.1. Company Overview
  • 9.6.2. Key Executives
  • 9.6.3. Company Snapshot
  • 9.6.4. Operating Business Segments
  • 9.6.5. Product Portfolio
  • 9.6.6. Business Performance
  • 9.6.7. Key Strategic Moves and Developments
• 9.7. Endalis
  • 9.7.1. Company Overview
  • 9.7.2. Key Executives
  • 9.7.3. Company Snapshot
  • 9.7.4. Operating Business Segments
  • 9.7.5. Product Portfolio
  • 9.7.6. Business Performance
  • 9.7.7. Key Strategic Moves and Developments
• 9.8. MEDSIL
  • 9.8.1. Company Overview
  • 9.8.2. Key Executives
  • 9.8.3. Company Snapshot
  • 9.8.4. Operating Business Segments
  • 9.8.5. Product Portfolio
  • 9.8.6. Business Performance
  • 9.8.7. Key Strategic Moves and Developments
• 9.9. Silimed Industria De Implantes Ltda.
  • 9.9.1. Company Overview
  • 9.9.2. Key Executives
  • 9.9.3. Company Snapshot
  • 9.9.4. Operating Business Segments
  • 9.9.5. Product Portfolio
  • 9.9.6. Business Performance
  • 9.9.7. Key Strategic Moves and Developments

관련자료